FEB 15, 2018 9:00 AM PST

What is a CAR-T cell therapy?


Most people must have heard revolutionary cancer therapy called CAR-T cell therapy, a kind of cancer immunotherapy. It has changed the landscape of cancer therapy and has the potential of curing some of the chemotherapy refractory blood cancer such as acute lymphoblastic leukemia (ALL).
Cancer immunotherapy is not a very new science, but it is the culmination of cumulative knowledge gained through countless experiments in immunology and cancer. In 1893, William Coley's observed reduction in tumor size upon injection of streptococcus bacteria. Giving BCG vaccine in early stage of bladder cancer is a form of oldest cancer immunotherapy which is still used in clinical practice.
T cells are the type of a white blood cell which plays an essential role in mounting an appropriate immune response to either diseased cells (virus-infected or cancer cells) or foreign pathogens. Cytotoxic T cells are central in killing cancerous cells. They recognize cancer cells through a particular receptor called T cell receptor (TCR) which binds to the novel antigen expressed only on cancer cells and thereby killing them. However, cytotoxic T cell which can recognize unique tumor antigen is scarce in number, or sometimes tumor itself create microenvironment to decrease their frequency around the tumor microenvironment. One way to overcome this challenge is to engineer T cells ex-vivo isolated from either blood of the patient or healthy individual. In this method, T cells are engineered to produce a single chain variable fragment of an antibody (chimeric antigen receptor; CAR) which recognizes unique antigen only expressed onto tumor cells, e.g., CD19 in case of ALL. They are expended in large number ex-vivo and injected into the patient, where further proliferation produces more engineered T cells specific to tumor cells. Expended CAR-T cells lead to complete killing of all tumor cells without harming healthy normal cells, unlike conventional cancer treatment where most of the side effects come from the killing of healthy cells. However, there are some challenges associated with CAR-T cell therapy such as cytokine storm and expensive nature of its production. Moreover, they are not currently suitable for solid tumors which constitute the majority of cancer found among the population.
FDA has recently approved two CAR-T cell therapy based on CD19 chimeric antigen receptor to treat ALL and diffuse large B cell lymphoma.
About the Author
  • Biological research scientist by profession with passion to write about science in general.
You May Also Like
DEC 22, 2019
Space & Astronomy
DEC 22, 2019
How Astronomers Measure Distances to Stars
Extra stellar systems are so far away from our own that we couldn’t even hope of developing a tape measure long enough to determine how far away they...
DEC 29, 2019
Space & Astronomy
DEC 29, 2019
The Dangers of Space Debris Explained
Humankind has become increasingly reliant on satellites and space technology to conduct everyday life, be it GPS for navigation on the road or satellite in...
JAN 13, 2020
Plants & Animals
JAN 13, 2020
An Albatross Mother's Work is Never Done
Albatross chicks are naturally flightless, and this increases their dependence on their parental units to bring back food for them to eat. In this chick&rs...
FEB 04, 2020
Space & Astronomy
FEB 04, 2020
What Are NASA's 'Great Observatories?'
NASA recently retired its Spitzer Space Telescope, one of four specialized space-based observatories that together made up the American Space Agency’...
FEB 11, 2020
Space & Astronomy
FEB 11, 2020
Why China Was Banned from the International Space Station
The International Space Station is just that – a place where international space agencies can work together in an effort to accomplish similar goals:...
FEB 17, 2020
Plants & Animals
FEB 17, 2020
How a Spider Builds its Web
Just about everyone has seen a spider web at some point in their life, but have you ever wondered how a spider builds such a strong and perfect web? The pr...
Loading Comments...